Patents Assigned to ORFONEURO APS
  • Treatment of neuronal ceroid lipofuscinosis
    Patent number: 12053510
    Abstract: The invention provides for novel treatments of lysosomal storage diseases, in particular of Neuronal Ceroid Lipofuscinosis (NCL) or synucleinopathy or a disease characterized by block of autophagic flow. The treatment comprises administration of human pro-Cathepsin, in particular human pro-Cathpsin D, B or L to patients in need thereof.
    Type: Grant
    Filed: May 1, 2019
    Date of Patent: August 6, 2024
    Assignee: ORFONEURO APS
    Inventors: Jens Morten Fogh, Paul Saftig, Friederike Zunke, André Rosa Alcalde Marques